1h Free Analyst Time
Chiesi USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.Speak directly to the analyst to clarify any post sales queries you may have.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company's operations and business divisions.
- Corporate strategy - The publisher's summarization of the company's business strategy.
- SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
Highlights
Chiesi USA Inc (Chiesi USA) is a subsidiary of Chiesi Farmaceutici SpA, a specialty pharmaceutical company. It researches, develops, produces, and commercializes therapies in cardiovascular, respiratory, neonatology, rare disease, and special care therapeutics. The company's product portfolio comprises of Cardene I.V. (nicardipine hydrochloride); Curosurf (poractant alfa); Zyflo (zileuton), Bethkis (tobramycin), Argatroban injection (Argatroban), Pertzye (pancrelipase), Kengreal (cangrelor), Cleviprex (clevidipine) and Retavase (reteplase). Its product pipeline encompasses drugs in key therapeutic areas of asthma, chronic obstructive pulmonary diseases, cardiovascular diseases, among others. It offers products to retail pharmacy chains, wholesalers, group purchasing organizations, hospital systems, and specialty pharmacies. Chiesi USA is headquartered in Cary, North Carolina, the US.Chiesi USA Inc Key Recent Developments
Feb 24, 2022: Chiesi USA certified as a Great Place to Work in 2021Dec 20, 2021: A new clinical framework redefines the diagnosis of COPD Exacerbations
Mar 18, 2021: Chiesi Group announces performance growth in 2020
Jan 21, 2021: Chiesi USA announces key promotions to business unit leads
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors' business structure and strategies with the publisher's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company’s Lifesciences Financial Deals and Alliances
Section 4 - Company’s Recent Developments
Section 5 - Appendix
List of Tables
List of Figures
Samples
LOADING...
Companies Mentioned
A selection of companies mentioned in this report includes:
- Novartis Pharmaceuticals Corp
- Windtree Therapeutics Inc
- Lupin Pharmaceuticals Inc
- Par Pharmaceutical Holdings Inc
- Eloxx Pharmaceuticals Inc
- Genentech USA Inc